Danish Pharmacovigilance Update, February 2015

16 March 2015

The February issue of Danish Pharmacovigilance Update with news from the EU, the DHMA and short news:

News from the EU

  • EMA tightens guidelines for use of hydroxyzine-containing medicines (Atarax®, etc.) to minimise the risk of heart rhythm disturbances, page 2
  • EU's list of recommendations on safety signals, page 3

News from the DHMA

  • Be aware of the risk of pulmonary fibrosis in long-term treatment with nitrofurantoin (Nitrofurantoin DAK) – new review and analysis by DHMA, page 4
  • The number of melatonin users under 25 years of age keeps increasing, page 5
  • DHMA keeps watch on isotretinoin for acne treatment, page 5
  • DHMA has focus on ADHD medicines and cardiovascular disturbances, page 6
  • Tramadol (Mandolgin®, etc.) and convulsions, page 7
  • Pay attention to patient's renal function before and during treatment with the non-vitamin K antagonists Pradaxa®, Eliquis and Xarelto®, page 8

Short news

  • Most recent Direct Healthcare Professional Communications (DHPCs), page 1


Danish Pharmacovigilance Update February 2015

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.